Sameh Morkous
Neurology with Special Qualifications in Child Neurology · Philadelphia, PANPI 1609036565
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,932 of the $2,679 with a category attached, or 72.1%. 11 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 32.8% of the total. Reporting peaked in 2019 at $1,313 and has fallen 77.9% since, to $290 in 2025.
Across 32 payments — averaging $83.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$880
- Eisai Inc.$478
- Neurelis, Inc.$301
- Jazz Pharmaceuticals Inc.$247
- Livanova USA, Inc.$240
- Greenwich Biosciences, Inc.$125
- plus $408 from 5 others
Across 42 payments — averaging $12,233 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mallinckrodt Hospital Products Inc.$325K
- Mallinckrodt Enterprises LLC$189K
What the payments were for
- Speaking & faculty fees$50019%
- Travel & lodging$1024%
- Food & beverage$1,93272%
- Education$1465%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 10 | $880 |
| Eisai Inc. | 6 | $478 |
| Neurelis, Inc. | 3 | $301 |
| Jazz Pharmaceuticals Inc. | 2 | $247 |
| Livanova USA, Inc. | 3 | $240 |
| Greenwich Biosciences, Inc. | 1 | $125 |
| Amgen | 1 | $112 |
| UCB, Inc. | 1 | $111 |
| Biomarin Pharmaceutical Inc. | 1 | $78 |
| AbbVie | 3 | $71 |
| Astellas Pharma US Inc | 1 | $37 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OXTELLAR XR$726
- Fycompa$332
- VALTOCO$235
- Epidiolex$125
- XYREM$125
- QELBREE$125
- XYWAV$122
- UPLIZNA$112
- Fintepla$111
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$101
How this compares
$2,679 in reported general payments places this provider in the 60th percentile of 83 neurology with special qualifications in child neurology providers in Pennsylvania.
See all neurology with special qualifications in child neurology providers in Pennsylvania →
Other neurology with special qualifications in child neurology in Philadelphia
- John BrandsemaPhiladelphia$526K
- Susan MatesanzPhiladelphia$138K
- Elizabeth KichulaPhiladelphia$90K
- Dennis DlugosPhiladelphia$88K
- Alexandra KornbluhPhiladelphia$88K
- Nicholas AbendPhiladelphia$56K
- Sabrina YumPhiladelphia$33K
- Eric MarshPhiladelphia$28K
- Christina SzperkaPhiladelphia$18K
- David LynchPhiladelphia$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.